Graduated Program in Pharmacology, Federal University of Santa Maria (UFSM), 97105-900 Santa Maria, RS, Brazil.
Graduated Program in Pharmacology, Federal University of Santa Maria (UFSM), 97105-900 Santa Maria, RS, Brazil.
Neurosci Biobehav Rev. 2023 Nov;154:105401. doi: 10.1016/j.neubiorev.2023.105401. Epub 2023 Sep 28.
Chronic pain is the most disability symptom related to multiple sclerosis (MS) brain lesions and can also generate anxiety and depression. There are no updated reports of the general prevalence of neuropathic pain, MS clinical types, sex dimorphism, and its association with depression and anxiety. The protocol was listed in PROSPERO (CRD42022303571). The article selection resulted in 24 studies with a low risk of bias. The prevalence of neuropathic pain in MS patients was 26.8% with higher levels of depression and anxiety. We also observed that female patients (74.2%) have a higher prevalence of neuropathic pain than males (28.9%). We showed the enhanced prevalence of neuropathic pain using the female and male data (58.9%) compared to the total prevalence (26.8%). In addition, the SPMS (40.3%) presented an increased prevalence of neuropathic pain compared to PPMS (15.6%). Thus, we demonstrated the association between neuropathic pain, depression and anxiety symptoms and the influence of diagnosis, age, disease score, and disease duration in the increased prevalence of neuropathic pain in MS patients.
慢性疼痛是与多发性硬化症(MS)脑损伤相关的最常见残疾症状,还可能引发焦虑和抑郁。目前尚无关于神经病理性疼痛的总体患病率、MS 临床类型、性别二态性及其与抑郁和焦虑的相关性的最新报告。该方案已在 PROSPERO(CRD42022303571)中列出。文章选择导致 24 项研究存在低偏倚风险。MS 患者的神经病理性疼痛患病率为 26.8%,且抑郁和焦虑程度更高。我们还观察到,女性患者(74.2%)的神经病理性疼痛患病率高于男性(28.9%)。与总患病率(26.8%)相比,我们使用女性和男性数据(58.9%)显示出神经病理性疼痛的患病率增加。此外,继发进展型多发性硬化症(SPMS)的神经病理性疼痛患病率(40.3%)高于原发进展型多发性硬化症(PPMS)(15.6%)。因此,我们证明了神经病理性疼痛、抑郁和焦虑症状之间存在关联,以及诊断、年龄、疾病评分和疾病持续时间对 MS 患者神经病理性疼痛患病率增加的影响。